HomeCompareSBHGF vs PFE

SBHGF vs PFE: Dividend Comparison 2026

SBHGF yields 6.53% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SBHGF wins by $10.04M in total portfolio value
10 years
SBHGF
SBHGF
● Live price
6.53%
Share price
$18.45
Annual div
$1.20
5Y div CAGR
60.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$10.09M
Annual income
$7,984,078.31
Full SBHGF calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — SBHGF vs PFE

📍 SBHGF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSBHGFPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SBHGF + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SBHGF pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SBHGF
Annual income on $10K today (after 15% tax)
$554.80/yr
After 10yr DRIP, annual income (after tax)
$6,786,466.56/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, SBHGF beats the other by $6,764,146.66/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SBHGF + PFE for your $10,000?

SBHGF: 50%PFE: 50%
100% PFE50/50100% SBHGF
Portfolio after 10yr
$5.07M
Annual income
$4,005,168.52/yr
Blended yield
78.98%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

SBHGF
No analyst data
Altman Z
0.9
Piotroski
7/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SBHGF buys
0
PFE buys
0
No recent congressional trades found for SBHGF or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSBHGFPFE
Forward yield6.53%6.13%
Annual dividend / share$1.20$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR60.6%13.2%
Portfolio after 10y$10.09M$49.6K
Annual income after 10y$7,984,078.31$26,258.71
Total dividends collected$9.88M$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: SBHGF vs PFE ($10,000, DRIP)

YearSBHGF PortfolioSBHGF Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$11,748$1,048.24$9,153$693.39+$2.6KSBHGF
2$14,419$1,848.40$8,593$849.25+$5.8KSBHGF
3$18,833$3,405.04$8,336$1,066.78+$10.5KSBHGF
4$26,827$6,675.38$8,437$1,384.80+$18.4KSBHGF
5$42,977$14,271.95$9,013$1,875.40+$34.0KSBHGF
6$80,302$34,316.79$10,306$2,680.72+$70.0KSBHGF
7$182,164$96,240.94$12,820$4,101.38+$169.3KSBHGF
8$522,602$327,685.81$17,673$6,826.70+$504.9KSBHGF
9$1,970,184$1,410,999.96$27,543$12,591.86+$1.94MSBHGF
10$10,092,175$7,984,078.31$49,560$26,258.71+$10.04MSBHGF

SBHGF vs PFE: Complete Analysis 2026

SBHGFStock

SBI Holdings, Inc. engages in the online financial service businesses and investment activities in Japan and internationally. It operates through Financial Services Business; Asset Management Business; Investment Business, Crypto-Asset Business and Non-financial Business segments. The company offers financial products and services, including brokerage and investment banking; Internet banking; auto, cancer, fire, and earthquake, as well as life insurance; short term insurance; FX margin trading; online securities; exchange and transaction services related to digital assets; management of defined-contribution pension, etc.; leasing and lending services; operation of proprietary trading system; control and operation of the e-commerce settlement business; and remittance and back office support services. It also provides private equity, venture capital fund management, M&A advisory, commercial banking, investment advisory and management, and rating information services; real estate secured loans; and rent guarantees for rental housing. In addition, the company researches, manufactures, and sells pharmaceutical products, health foods, and cosmetics; develops, produces, sells, and maintains medical information integration systems; and researches and develops antibody drugs and nucleic acid medicines for cancer and immunology. Further, it operates a fund-raising platform; acts as a crypto-asset broker; develops, manufactures, and sells crypto-asset mining systems; operates and develops cybersecurity systems; provides blockchain platform; invests in real estate properties; exports used cars; and offers healthcare services, as well as revitalization services. Additionally, the company engages in the mining of digital assets; and e-sports and renewable energy business. The company was formerly known as Softbank Investment Corporation and changed its name to SBI Holdings, Inc. in July 2005. SBI Holdings, Inc. was incorporated in 1999 and is headquartered in Tokyo, Japan.

Full SBHGF Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this SBHGF vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SBHGF vs SCHDSBHGF vs JEPISBHGF vs OSBHGF vs KOSBHGF vs MAINSBHGF vs JNJSBHGF vs MRKSBHGF vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.